Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3616 (miR-3616) is a member of the microRNA (miRNA) family, a class of endogenous, small (about 22 nucleotides), non-coding RNA molecules that regulate gene expression at the post-transcriptional level. MicroRNAs are transcribed from specific genes and act by binding to target messenger RNAs (mRNAs), leading to translational repression or degradation of the mRNA. This regulatory mechanism plays a critical role in various cellular processes, including differentiation, proliferation, apoptosis, and development[1][2][3]. miR-3616 is one of many miRNAs annotated in the human genome, but there is currently no direct evidence suggesting that this particular microRNA functions as a therapeutic target or is implicated in a specific human disease. Like other microRNAs, its primary known function is the regulation of gene expression through RNA silencing mechanisms[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3616 (miR-3616).